| 4.190 -0.060 (-1.41%) 03-03 14:31 |
|
| Open: | 4.210 |
| High: | 4.380 |
| Low: | 4.170 |
| Pre. close: | 4.250 |
| Volume: | 89,036 |
| Avg. volume: | 90,630 |
| MA (50): | 4.730 |
| MA (200): | 5.497 |
| Year high: | 7.700 |
| Year low: | 4.020 |
| Market cap: | 94(M) |
| EPS: | -0.24 |
| PE ratio: | -17.46 |
| SELL | BUY |
| HeikinAshi: | |
| Kaufmans AMA: | |
| Chandelier (20): | |
| MA (5): | |
| MA (50): | |
| MACD (26,12,9): | |
| Slow KDJ (14,3): | |
| RSI (14): | |
| CCI (20): |
Mon, 02 Mar 2026
OSE Immunotherapeutics Accelerates Strategic Refocusing to Advance Late Stage Value Drivers Lusvertikimab and Tedopi - marketscreener.com
Thu, 26 Feb 2026
OSE Immunotherapeutics Receives Second Positive IDMC Recommendation for Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer - GlobeNewswire
Mon, 09 Feb 2026
We Think OSE Immunotherapeutics (EPA:OSE) Has A Fair Chunk Of Debt - simplywall.st
Mon, 08 Dec 2025
OSE Immunotherapeutics Announces Strategic Amendment to AbbVie’s Partnership on ABBV-230 Development - GlobeNewswire
Mon, 08 Dec 2025
OSE Immunotherapeutics Unveils 2026–2028 Strategic Plan With Four Opportunities for Value Creation - Yahoo Finance
Wed, 15 Oct 2025
OSE Immunotherapeutics Reports First Half 2025 Financial Results - Yahoo Finance
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.